Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:15 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 7,865 matching trials from the live ClinicalTrials.gov search.

Filters: Minneapolis, Minnesota Clear all

Conditions: Metastatic Cancer
Interventions: surgical procedure; Procedure
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 530 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2007
U.S. locations: 45
States / cities: La Jolla, California • San Francisco, California • Wilmington, Delaware + 27 more

Conditions: COVID-19
Interventions: FT516; Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years to 76 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Smoking Cessation
Interventions: CP-526,555 (varenicline); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 625 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2002
U.S. locations: 7
States / cities: Los Angeles, California • Farmington, Connecticut • Minneapolis, Minnesota + 4 more

Conditions: Cardiomyopathy Due to Anthracyclines
Interventions: Allo-MSCs, Placebo; Biological
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 79 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 7
States / cities: Stanford, California • Gainesville, Florida • Miami, Florida + 4 more

Conditions: Cognition
Interventions: Ready-To-Eat Cereal; Other
Lead sponsor: General Mills; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: COVID-19
Interventions: MP0420, Placebo, Remdesivir; Drug · Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 485 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 73
States / cities: Tucson, Arizona • Chula Vista, California • Fresno, California + 52 more

Conditions: Obstructive Sleep Apnea
Interventions: Inspire therapy, No intervention; Device · Other
Lead sponsor: Inspire Medical Systems, Inc.; Industry
Eligibility: Not listed
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 53
States / cities: Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 43 more

Conditions: Breast Cancer, Osteoporosis
Interventions: calcium salts, cholecalciferol, zoledronic acid; Dietary Supplement · Drug
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 40 Years and older · Female only
Enrollment: 439 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2009
U.S. locations: 107
States / cities: Arroyo Grande, California • La Jolla, California • Mountain View, California + 80 more

Conditions: HIV Infections, Peripheral Nervous System Disease
Interventions: Mexiletine hydrochloride, Benztropine mesylate, Amitriptyline hydrochloride; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1997
U.S. locations: 36
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 23 more

Conditions: Prolapse, Urinary Incontinence, Fecal Incontinence, Bladder Pain Syndrome
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Metastatic Melanoma, Pulmonary Metastases, Hepatic Metastases, Brain Metastases
Interventions: Interleukin-2 & Ipilimumab (P-Ib), Interleukin-2 & Ipilimumab (P-II); Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Blood or Marrow Transplant
Interventions: BMT Legal Clinic; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Head Injury
Interventions: Head CT Decision Aid; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: Up to 18 Years
Enrollment: 971 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 7
States / cities: Sacramento, California • Boston, Massachusetts • Minneapolis, Minnesota + 3 more

Conditions: Osteoporosis, Liver Transplantation
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 16 Years to 40 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Major Depression
Interventions: Pharmacogenetic Test; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 1,944 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 24
States / cities: North Little Rock, Arkansas • Palo Alto, California • San Francisco, California + 21 more

Conditions: Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8
Interventions: Capecitabine, Fluorouracil, Leucovorin, Leucovorin Calcium, Oxaliplatin, Patient Observation; Drug · Other
Lead sponsor: NRG Oncology; Other
Eligibility: 18 Years and older
Enrollment: 635 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 932
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 639 more

Conditions: COPD
Interventions: myAirvo3, Pulse oximeter; Device
Lead sponsor: Temple University; Other
Eligibility: 30 Years and older
Enrollment: 642 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 25
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Jacksonville, Florida + 20 more

Conditions: Pulmonary Embolism
Interventions: Indigo Aspiration System; Device
Lead sponsor: Penumbra Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 58
States / cities: Long Beach, California • Los Angeles, California • Orange, California + 48 more

Conditions: Becker Muscular Dystrophy, Muscular Dystrophies, Muscular Dystrophy in Children, Muscular Dystrophy, Becker
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 6 Years and older · Male only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 9
States / cities: Orange, California • Aurora, Colorado • Iowa City, Iowa + 6 more

Conditions: Immune-related Colitis, Colitis
Interventions: RMT, Placebo; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 9
States / cities: Brainerd, Minnesota • Deer River, Minnesota • Detroit Lakes, Minnesota + 6 more

Conditions: Head and Neck Cancer, Mucositis, Oral Complications of Radiation Therapy, Pain
Interventions: doxepin hydrochloride, placebo; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 120
States / cities: Scottsdale, Arizona • Hartford, Connecticut • Jacksonville, Florida + 77 more

Conditions: Smoker
Interventions: Cigarettes, Snus; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 3
States / cities: Minneapolis, Minnesota • Buffalo, New York • Columbus, Ohio

Conditions: Cystic Fibrosis
Interventions: Not listed
Lead sponsor: Vertex Pharmaceuticals Incorporated; Industry
Eligibility: Up to 6 Months
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 22
States / cities: St. Petersburg, Florida • Boise, Idaho • Chicago, Illinois + 19 more

Conditions: Tri-specific Killer Engager, Solid Tumor, Advanced Solid Tumor
Interventions: GTB-5550; Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases

Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia

A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation

Stem Cell Injection in Cancer Survivors

Appetite and Cognition Response to a Breakfast Cereal

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

What is the Prevalence of Female Pelvic Floor Disorders in Minnesota?

Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma

Medical-legal Partnership (MLP) to Support Bone Marrow Transplant

Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice

Osteoporosis in Children and Adults Following Liver Transplantation

PRIME Care (PRecision Medicine In MEntal Health Care)

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

Defining Endpoints in Becker Muscular Dystrophy

A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Methods Project 4: Clinical Trial

Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

GTB-5550 in Advanced Solid Tumors